On January 5, 2016, Ruehter, Gerd; Koch, Uwe; Nussbaumer, Peter; Schulz-Fademrecht, Carsten; Eickhoff, Jan published a patent.Application of 1187830-46-1 The title of the patent was Pharmaceutically active disubstituted triazine derivatives. And the patent contained the following:
The present invention relates to disubstituted triazine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, immunol. diseases, autoimmune diseases, cardiovascular diseases, cell proliferative diseases, inflammation, erectile dysfunction and stroke, and pharmaceutical compositions containing at least one of said disubstituted triazine derivatives and/or pharmaceutically acceptable salts thereof. Furthermore, the present invention relates to the use of said disubstituted triazine derivatives as inhibitors for a protein kinase. The experimental process involved the reaction of 6,7-Dihydro-5H-pyrrolo[3,4-d]pyrimidine hydrochloride(cas: 1187830-46-1).Application of 1187830-46-1
The Article related to triazine derivative infection immune autoimmune cardiovascular proliferation disease preparation, erectile dysfunction stroke triazine derivative protein kinase inhibitor and other aspects.Application of 1187830-46-1
Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia